MENU
PRLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Prelude Therapeutics (PRLD) Earnings Date & Reports
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients... Show more
A.I. Advisor
published Earnings
PRLD is expected to report earnings to fall 210.23% to 14 cents per share on November 05
Q3'26
Est.
$0.14
Q1'26
Beat
by $0.10
Q4'25
Missed
by $0.07
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.07
The last earnings report on May 12 showed earnings per share of -12 cents, beating the estimate of -23 cents. With 284.13K shares outstanding, the current market capitalization sits at 367.10M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
79
Web
https://www.preludetx.com